Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Crossref DOI link: https://doi.org/10.1007/s11684-017-0506-y
Published Online: 2017-03-27
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lou, Yinjun
Ma, Yafang
Li, Chenyin
Suo, Sansan
Tong, Hongyan
Qian, Wenbin
Mai, Wenyuan
Meng, Haitao
Yu, Wenjuan
Mao, Liping
Wei, Juyin
Xu, Weilei
Jin, Jie
License valid from 2017-03-27